Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples
Royal Brompton Hospital · NIHR Royal Brompton Cardiovascular Biomedical Research Unit · +11 more institutions
Abstract
We analyzed sequence data from 7,855 clinical cardiomyopathy cases and 60,706 Exome Aggregation Consortium (ExAC) reference samples to obtain a better understanding of genetic variation in a representative autosomal dominant disorder.
We found that in some genes previously reported as important causes of a given cardiomyopathy, rare variation is not clinically informative because there is an unacceptably high likelihood of false-positive interpretation. By contrast, in other genes, we find that diagnostic laboratories may be overly conservative when assessing variant pathogenicity.
Citation impact
- FWCI
- 60.49
- Percentile
- 100%
- References
- 43
Authors
15- RWRoddy Walsh
Royal Brompton Hospital, NIHR Royal Brompton Cardiovascular Biomedical Research Unit, Imperial College London
- KTKate Thomson
Churchill Hospital, University of Oxford
- JSJames S. Ware
Royal Brompton Hospital, NIHR Royal Brompton Cardiovascular Biomedical Research Unit, Imperial College London
- BFBirgit Funke
Harvard University, Massachusetts General Hospital, Mass General Brigham
- JWJessica Woodley
Churchill Hospital, University of Oxford
Topics & keywords
- Mendelian inheritance
- Exome sequencing
- Exome
- Genetics
- Computational biology
- Pedigree chart
- Cardiomyopathy
- Biology
Funding
- WTWellcome TrustAwards: 090532, 090532/Z/09/Z, 090532/Z/09/
- DMDuke-NUS Medical School
- TFTanoto Foundation
- NINational Institute for Health and Care ResearchAward: NIHR-HCS-D13-04-006
- BHBritish Heart FoundationAwards: 090532/Z/09/Z, RE/13/1/30181
- AOAcademy of Medical Sciences
- ICImperial College London
- UOUniversity of OxfordAward: RE/13/1/30181
- FLFondation Leducq
- BCBHF Centre of Research Excellence, OxfordAward: RE/13/1/30181
- OUOxford University Hospitals NHS Foundation Trust
- NINational Institutes of HealthAward: U54DK105566
- MRMedical Research CouncilAward: 13/1/30181
- NMNational Medical Research Council
- NONIHR Oxford Biomedical Research CentreAward: 090532/Z/09/Z